Y.Enterocolitica (O:9) YopE

Yersinia Enterocolitica (O:9) YopE Recombinant
Cat. No.
BT27083
Source

Escherichia Coli.

Synonyms

Outer membrane virulence protein YopE, yopE, yop25.

Appearance

Sterile Filtered clear solution.

Purity

Greater than 80.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Yersinia Enterocolitica (O:9) YopE in E.coli is a non-glycosylated, polypeptide chain having a calculated molecular mass of 24kDa.

Y.Enterocolitica (O:9) YopE is expressed with a -10x His tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Yersinia enterocolitica, a pathogenic bacterium, utilizes a plasmid-encoded type 3 secretion system to inject Yersinia outer proteins (Yops) into host cells. Among these Yops, YopE functions as a GTPase activation protein that disrupts the host cell's actin cytoskeleton. It achieves this by activating small Rho GTPases, leading to the inhibition of actin polymerization and ultimately affecting cellular processes.
Description
Recombinant Yersinia enterocolitica (O:9) YopE, produced in E.coli, is a non-glycosylated polypeptide chain with a calculated molecular mass of 24kDa. This protein is expressed with a -10x His tag at its N-terminus to facilitate purification, which is carried out using proprietary chromatographic techniques.
Physical Appearance
The product is a clear solution that has been sterilized through filtration.
Formulation
Y.Enterocolitica (O:9) YopE is provided in a buffer solution containing 20mM HEPES (pH 7.6), 250mM NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be kept at 4°C. For longer periods, it should be stored frozen at -20°C. To maintain product integrity, avoid repeated freeze-thaw cycles.
Purity
The purity of the recombinant Y.Enterocolitica (O:9) YopE is determined by SDS-PAGE analysis and is confirmed to be greater than 80%.
Synonyms

Outer membrane virulence protein YopE, yopE, yop25.

Source

Escherichia Coli.

Immunological Activity
Binds IgG- and IgM-type human antibodies.

Product Science Overview

Introduction

Yersinia enterocolitica is a pathogenic bacterium responsible for causing yersiniosis, a zoonotic disease that affects both humans and animals. This bacterium is known for its diverse serotypes and biotypes, with O:9 being one of the significant serotypes. A key virulence factor of pathogenic Yersinia enterocolitica strains is the Yersinia outer protein E (YopE), which plays a crucial role in the bacterium’s ability to infect and survive within the host.

Yersinia Outer Protein E (YopE)

YopE is a part of the type III secretion system (T3SS), a sophisticated mechanism used by Yersinia enterocolitica to inject virulence proteins directly into the host cells. This system is encoded by a plasmid and is essential for the bacterium’s pathogenicity. YopE functions as a GTPase-activating protein (GAP), which targets and inactivates small Rho GTPases in the host cell. This action leads to the inhibition of actin polymerization, disrupting the host cell’s cytoskeleton and aiding in the bacterium’s evasion of the host’s immune response .

Recombinant YopE

Recombinant YopE is produced using Escherichia coli (E. coli) as a host for expression. The recombinant protein is typically non-glycosylated and has a calculated molecular mass of approximately 24 kDa. It is often expressed with a His-tag at the N-terminus to facilitate purification through chromatographic techniques .

The recombinant YopE protein is supplied in a buffer solution containing HEPES, NaCl, and glycerol to ensure stability. It is crucial to store the protein at low temperatures, typically at -20°C or below, to maintain its integrity and avoid multiple freeze-thaw cycles .

Applications and Importance

Recombinant YopE is primarily used for laboratory research purposes. It is instrumental in studying the molecular mechanisms of Yersinia enterocolitica’s pathogenicity and the host-pathogen interactions. By understanding how YopE manipulates the host cell’s cytoskeleton, researchers can develop targeted therapies and preventive measures against yersiniosis.

Additionally, recombinant YopE can be used in immunological studies to investigate the immune response elicited by this virulence factor. It binds to IgG- and IgM-type human antibodies, making it a valuable tool for developing diagnostic assays and vaccines .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.